Table 4.
Performance of PNN for identifying Src inhibitors and non-inhibitors evaluated by 5-fold cross validation study
| Cross - validation |
Src inhibitors |
Src non-inhibitors |
Q | C | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No of training/ testing inhibitors | TP | FN | SE | No of training/testing non-inhibitors | TN | FP | SP | |||
| 1 |
1362/341 |
319 |
22 |
93.55% |
50654/12664 |
12413 |
251 |
98.02% |
97.90% |
0.715 |
| 2 |
1362/341 |
324 |
17 |
95.01% |
50654/12664 |
12380 |
284 |
97.76% |
97.69% |
0.702 |
| 3 |
1362/341 |
330 |
11 |
96.77% |
50654/12664 |
12395 |
269 |
97.88% |
97.85% |
0.722 |
| 4 |
1363/340 |
330 |
10 |
97.06% |
50655/12663 |
12389 |
274 |
97.84% |
97.82% |
0.720 |
| 5 |
1363/340 |
318 |
22 |
93.53% |
50655/12663 |
12413 |
250 |
98.03% |
97.91% |
0.715 |
| Average |
|
|
|
95.19% |
|
|
|
97.90% |
97.83% |
0.715 |
| SD |
|
|
|
0.0169 |
|
|
|
0.0012 |
0.0009 |
0.0075 |
| SE | 0.0076 | 0.0005 | 0.0004 | 0.0034 | ||||||